The APA is committed to advocating for the field of psychology and its role in promoting health, education, and human welfare. Such advocacy initiatives include delivering testimonies in response to federal legislative and regulatory issues. Behavioral health interventions, including a “whole person approach”, are vital to addressing the opioid epidemic, APA CEO tells Congress.

A “Whole Person” Approach is Needed to Solve the Opioid Epidemic, Says APA August 07, 2019

A new study evaluated self-reported cannabis use in pregnancy and maternal, perinatal, and neonatal outcomes. Read more in the latest EBM Focus.

EBM Focus: Antenatal Cannabis Use May Increase Risk of Preterm Delivery August 06, 2019

Aflibercept may not be worth the cost for patients with diabetic macular edema and good visual acuity. Read more in the latest EBM Focus.

EBM Focus: Aflibercept for Diabetic Macular Edema with Preserved Visual Acuity — Seeing Dollar Signs July 29, 2019

Read about the most widely used sideline tool for assessing concussions, the Sports Concussion Assessment Tool - 5th Edition (SCAT5).

Sideline Concussion Assessment Standard: A Review of the Utility of SCAT5 July 23, 2019

A possible increased risk of skin cancer with thiazide diuretics is unlikely to change prescribing. Read more in the latest EBM Focus.

EBM Focus: Thiazide Diuretics and Skin Cancer? Don’t Get Burned by the Hype July 10, 2019

Clinical educator Dan Ostrovsky, Associate Professor of Internal Medicine and Pediatrics at Duke University, offers teaching tips to maximize new resident understanding and lifelong learning.

Teaching Tips for Clinical Educators at the Start of the New Internship/Resident Year June 27, 2019

A new trial adds to the evidence that MMR vaccination does not increase risk of autism, even among high-risk children.

EBM Focus: Continuing to Debunk Ties Between MMR Vaccination and Autism Spectrum Disorder June 25, 2019

Read about the GRADE Working Group’s recently published paper in BMJ Open on decision-making via certainty of net benefit, lead author Dr. Brian Alper MD, MSPH, FAAFP, Founder of DynaMed and Vice President of Innovations and EBM Development at EBSCO Information Services.

Defining Certainty of Net Benefit: A Concept Years in the Making June 24, 2019

A new trial adds to the evidence for a benefit of thrombolytics for stroke beyond four and a half hours.

EBM Focus: Pushing the needle — Benefit of Thrombolytics for Stroke beyond Four and a Half Hours June 18, 2019

Popular Tags

Other EBSCO Sites +–